Medicare Enrolled
Dr. Stephen Lapin, M.D.
Optician · Houston, TX
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Lapin from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Lapin?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Lapin
Dr. Stephen Lapin is an optician specialist in Houston, TX, with 20 years of NPI registration. Based on federal Medicare data, Dr. Lapin performed 7,060 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Lapin received a total of $12,770 from 73 pharmaceutical and/or device companies across 629 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Lapin is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years of NPI registration
▲ Top 10% volume in TX
$12,770 industry payments
Medicare Practice Summary — 2023
Medicare Utilization ↗7,060
Medicare services
Top 10% in TX for optician
Not available
Unique patients (not deduplicated)
$40
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Automated urinalysis An automated laboratory test performed on a urine sample to analyze its chemical and physical properties. The procedure uses machinery to detect various substances and cells within the urine. |
1,536 | $2 | $2 |
| Chronic care management, first 20 min/month This service covers the first 20 minutes of clinical staff time directed by a healthcare professional each calendar month to manage chronic conditions. |
1,370 | $46 | $65 |
| Bladder ultrasound after voiding An ultrasound scan performed after urination to measure the amount of urine remaining in the bladder. |
980 | $8 | $11 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
906 | $93 | $134 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
824 | $8 | $9 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
673 | $64 | $95 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
154 | $120 | $174 |
| Cystourethroscopy A diagnostic exam of the bladder and urethra using an endoscope to visually inspect the urinary tract. |
120 | $60 | $258 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
57 | $61 | $87 |
| Bladder instillation of anti-cancer drug A procedure where an anti-cancer medication is introduced directly into the bladder. This method delivers the treatment locally to the bladder tissue. |
56 | $67 | $91 |
| Imaging of urinary tract with contrast An imaging test of the urinary tract performed after a contrast agent is injected to enhance visibility of the structures. |
41 | $20 | $31 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
32 | $11 | $15 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
29 | $134 | $185 |
| Hospital follow-up visit, low complexity Follow-up hospital visit for an established patient with straightforward or low-level medical decision making. The visit requires at least 25 minutes of time spent on the day of service. |
25 | $41 | $51 |
| Bladder irrigation and/or instillation This procedure involves flushing the bladder with fluid to clear it or introducing medication directly into the bladder. |
23 | $63 | $79 |
| Electronic assessment of bladder emptying A test that uses electronic monitoring to evaluate how well the bladder empties urine. |
23 | $6 | $15 |
| Ureteral stent insertion via endoscope A flexible tube is inserted into the ureter using an endoscope to keep the passage open and allow urine to flow from the kidney to the bladder. |
22 | $105 | $453 |
| Complete ultrasound of retroperitoneum An ultrasound examination of the structures located behind the abdominal cavity. |
22 | $57 | $79 |
| Prostate gland biopsy A procedure to remove small samples of tissue from the prostate gland for laboratory examination. |
21 | $105 | $251 |
| Transrectal ultrasound of the pelvis An ultrasound imaging procedure where a probe is inserted into the rectum to visualize pelvic structures. |
21 | $26 | $33 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
18 | $119 | $209 |
| Telephone medical discussion, 11-20 minutes A phone conversation with a physician lasting between 11 and 20 minutes. |
18 | $71 | $93 |
| Shock wave crushing of kidney stones A procedure that uses shock waves to break kidney stones into smaller pieces so they can pass more easily from the body. |
16 | $481 | $765 |
| Ureteral stone crushing with stent insertion An endoscope is used to break up a stone in the ureter, followed by the placement of a stent to keep the ureter open. |
16 | $324 | $425 |
| Ultrasound guidance for needle placement Use of ultrasound imaging to guide the precise placement of a needle during a medical procedure. |
16 | $25 | $31 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
15 | $108 | $144 |
| Transurethral prostate removal with electrocautery This procedure involves removing the prostate gland through the urethra using an endoscope and an electrocautery knife to control bleeding. |
14 | $581 | $819 |
| Telephone medical discussion, 5-10 minutes A phone conversation with a physician lasting between 5 and 10 minutes to discuss medical matters. |
12 | $42 | $58 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
0.5% high complexity
16.0% medium
83.4% routine
Industry Payment Transparency
Open Payments through 2024 ↗$12,770
Total received (2018-2024)
Avg $1,824/year across 7 years
Top 14% in TX for optician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
73
Companies
629
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$2,508
2023
$2,216
2022
$2,180
2021
$951
2020
$794
2019
$2,494
2018
$1,626
Payments by company (2024)
Myriad Genetic Laboratories, Inc.
$302
Sumitomo Pharma America, Inc.
$286
Ferring Pharmaceuticals Inc.
$236
Astellas Pharma US Inc
$217
ABBVIE INC.
$155
Antares Pharma, Inc.
$137
Dendreon Pharmaceuticals LLC
$121
Bayer Healthcare Pharmaceuticals Inc.
$109
Endo USA, Inc.
$98
PROCEPT BioRobotics Corporation
$90
Ambu Inc.
$71
PROGENICS PHARMACEUTICALS, INC.
$68
UROGEN PHARMA, INC.
$62
Baxter Healthcare
$61
PFIZER INC.
$53
HealthTronics Stone Solutions, LLC
$49
Avanos Medical
$38
Blue Earth Diagnostics Limited
$36
Medtronic, Inc.
$35
BIOTISSUE HOLDINGS INC.
$33
Axonics, Inc.
$29
Janssen Biotech, Inc.
$27
SUN PHARMACEUTICAL INDUSTRIES INC.
$27
IMMUNITYBIO, INC.
$24
Verity Pharmaceuticals Inc.
$22
Olympus America Inc.
$20
AngioDynamics, Inc.
$20
Boston Scientific Corporation
$19
Provepharm Inc.
$19
MILLICENT US INC
$16
Tolmar, Inc.
$16
Amgen Inc.
$14
Top 3 companies account for 32.9% of 2024 payments
All-time payments by company (2018-2024) ›
Astellas Pharma US Inc
$1,440
Boston Scientific Corporation
$923
PFIZER INC.
$843
Janssen Biotech, Inc.
$799
Myriad Genetic Laboratories, Inc.
$795
ABBVIE INC.
$548
Sumitomo Pharma America, Inc.
$541
Ferring Pharmaceuticals Inc.
$498
Amgen Inc.
$497
Endo Pharmaceuticals Inc.
$411
BOSTON SCIENTIFIC CORPORATION
$406
Progenics Pharmaceuticals, Inc.
$398
Antares Pharma, Inc.
$338
Dendreon Pharmaceuticals LLC
$312
Allergan Inc.
$253
Bayer Healthcare Pharmaceuticals Inc.
$219
Myovant Sciences Inc.
$217
Coloplast Corp
$201
ConvaTec Inc.
$198
UROVANT SCIENCES INC
$184
AbbVie, Inc.
$175
Allergan, Inc.
$158
AstraZeneca Pharmaceuticals LP
$148
Ambu Inc.
$124
Bayer HealthCare Pharmaceuticals Inc.
$115
UroGen Pharma, Inc.
$109
AngioDynamics, Inc.
$99
Endo USA, Inc.
$98
Blue Earth Diagnostics Limited
$97
PROCEPT BioRobotics Corporation
$90
UROGEN PHARMA, INC.
$87
AbbVie Inc.
$86
Aytu BioScience, Inc
$82
PROGENICS PHARMACEUTICALS, INC.
$68
Baxter Healthcare
$61
Axonics Modulation Technologies, Inc.
$60
Axonics, Inc.
$60
Supernus Pharmaceuticals, Inc.
$59
Merck Sharp & Dohme LLC
$56
GENZYME CORPORATION
$51
CSL Behring
$51
HealthTronics Stone Solutions, LLC
$49
BIOTISSUE HOLDINGS, INC.
$42
Olympus America Inc.
$40
Avanos Medical
$38
Mission Pharmacal Company
$36
Medtronic, Inc.
$35
BIOTISSUE HOLDINGS INC.
$33
Alexion Pharmaceuticals, Inc.
$32
Acerus Pharmaceuticals Corporation
$29
NxThera, Inc.
$27
Teleflex LLC
$27
SUN PHARMACEUTICAL INDUSTRIES INC.
$27
Avadel Specialty Pharmaceuticals, LLC
$26
Duchesnay USA Incorporated
$25
180 Medical, Inc.
$25
Merck Sharp & Dohme Corporation
$24
IMMUNITYBIO, INC.
$24
ACCORD HEALTHCARE, INC.
$24
TherapeuticsMD, Inc.
$24
Verity Pharmaceuticals Inc.
$22
Pacira Pharmaceuticals Incorporated
$21
Janssen Pharmaceuticals, Inc
$20
RGH Enterprises, Inc.
$19
Provepharm Inc.
$19
DENTSPLY IH Inc.
$19
Abbott Laboratories
$19
Retrophin, Inc.
$19
MILLICENT US INC
$16
Tolmar, Inc.
$16
AKRIMAX PHARMACEUTICALS, LLC
$15
BioTissue Holdings, Inc.
$14
EDAP TECHNOMED INC
$12
Top 3 companies account for 25.1% of all-time payments
Associated products mentioned in payments ›
(815) Thiola · ADSTILADRIN · ALTIS · AMS 700 CXR RTE KIT · ANKTIVA · AQUABEAM SYSTEM · AVEED · Altis · Androgel · Axium INS DRG IPG · Axonics · Axonics r-SNM System · Axumin · BLUDIGO · BOTOX · BOTOX THERAPEUTIC · BRAC CDx · BRACANALYSIS CDX · BRACAnalysis CDx · CAMCEVI · CERVIDIL · CLENPIQ · Dornier MedTech · EDEX · ELIGARD · ERLEADA · EXPAREL · Erleada · FEMRING · FIRMAGON · GEMTESA · GENERAL BPH · GENERAL FEMALE SUI · GENERAL KIDNEY STONE DISEASE · GENERAL - BPH · GENERAL - KIDNEY STONE DISEASE · GENERAL BPH · GENTLECATH · General - BPH · Haegarda · IMVEXXY · INTERSTIM · JELMYTO · JEVTANA · KEYTRUDA · Kcentra · LITHOVUE · LUPRON DEPOT · LYNPARZA · LoFric · Lupron · Lupron Depot · MYRBETRIQ · Myrbetriq · NANOKNIFE · NEOX · NOCDURNA · Natesto · Noctiva · Nubeqa · ON-Q* PUMP AND ACCESSORIES · ORGOVYX · Osphena · PERCLOT · POSLUMA · PROLARIS · PROVENGE · PYLARIFY · Prolia · REZUM · Rezum · SpaceOAR VUE System - 10mL · TITAN · TLANDO · TOVIAZ · ThunderBeat · Trelstar · ULTOMIRIS · UROLIFT · Uribel · VESICARE · XIAFLEX · XTANDI · XYOSTED · Xofigo · Xtandi · YONSA · iTIND System
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Opticians in nearby ZIP areas
524
County median income
$73,104
Nearest hospital to ZIP centroid (approximate)
MEMORIAL HERMANN - TEXAS MEDICAL CENTER
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Lapin is a clinical cardiology specialist, with above-average Medicare volume (top 10% in TX), with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Lapin experienced with automated urinalysis?
Based on Medicare claims data, Dr. Lapin performed 1,536 automated urinalysis services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Lapin receive payments from pharmaceutical companies?
Yes. Dr. Lapin received a total of $12,770 from 73 companies across 629 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Lapin's costs compare to other opticians in Houston?
Dr. Lapin's average Medicare payment per service is $40. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Lapin) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Same specialty & city
Opticians in Houston
Browse opticians in Houston ranked by procedure volume and transparency data.
Highest volume
Top Opticians in TX
Opticians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Opticians in TX
Which TX opticians receive the most from drug and device companies.
By company
Astellas Pharma US Inc Payments to Doctors
See all physicians who received payments from Astellas Pharma US Inc.
By company
Boston Scientific Corporation Payments to Doctors
See all physicians who received payments from Boston Scientific Corporation.
By company
PFIZER INC. Payments to Doctors
See all physicians who received payments from PFIZER INC.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology